In Vitro Effect of Alfa Mangostin on Multiresistant Uropathogenic Escherichia Coli
DOI:
https://doi.org/10.30659/sainsmed.v8i1.1002Keywords:
MDR, antibiotic, Garcinia mangostana L.Abstract
Introduction: In Indonesia, the most commom uropatogen E. coli resistance has been to ampicillin (91.9%), ciprof loxacin (83.7%) and cefixime (67.6%). α-mangostin, a chemical compound, has been developed as a new antibiotics isolaated from herbal Garcinia mangostana L, but its effectiveness against multiresistant uropathogenic E. Coli has not been established.
Objective: This study examined the effect of α-mangostin on growth of multiresistant E. coli
Methods: α-mangostin Treatment of E. coli uropatogen bacteria was administered in vitro, using 14 levels of concentration 14; 28,13; 56.25; 112.5;225; And 450 μg/mL with 4 times replication at each concentration. The antibacterial activity of α-mangostin was determined by evaluating bacterial growth at each concentration using the indirect method by sample absorbance reading. The Samples of uropatogen of E. coli treated with various doses of α-mangostin were incubated for 18-20 hours and then subjected to the absorbance reading using a UV-Vis spectrophotometer λ 625 nm.
Results: Minimum inhibitory concentration (MIC) in this study was 450 mg/mL. Based on linear regression (STATA 13.1) relationship between
α-mangostin concentrations and bacterial growth inhibition activity showed 0.0001 <0.05 showing that all concentrations of α-mangostin simultaneously had a significant effect on the growth of uropathogenic E. coli.
Conclusion: α-mangostin has not been effective to inhibit the growth of multiresistent uropathogentic E. coli due to a relatively high MIC (450 mcg/mL).a Potentially relevant activity in the clinical setting will occur if the value of the MIC of a substance in vitro <100 μg /mL. Even the pharmaceutical industry prefers the development of antibiotics with in vitro MIC value of ≤ 2 μg/mL.
References
Alhashash, F., Weston, V., Diggle, M., and McNally, A. 2013. Multidrug-resistant Escherichia coli bacteremia. Emerging Infectious Disease Vol. 19(10): 1699-1701
Allen, ME. 2005. MacConkey agar plates protocol. American Society for Microbiology: 1-4
Al Massarani SM., El Gamal AA., Al Musayeib, NM., Mothana RA., Basudan OA., Al Rehaily AJ., et al. 2013. Phytochemical, antimicrobial, and antiprotozoal evaluation of Garcinia mangostana pericarp and a- mangostin, its major xanthone derivative. Molecules Vol. 18: 10599-10608
Baral, P., Neupane, S., Marasini, BP., Ghimire, KR., Lekhak, B., and Shrestha, B. 2012. High prevalence of multidrug resistance in bacterial uropathogens from Kathmandu, Nepal. BMC Research Notes Vol. 5(38): 1-9
Bhat, RS., and Daihan, S. 2013. Antimicrobial activity of Garcinia mangostana using different solvents extracts. Int. J. Biosci Vol. 3(10): 267-272
Brunner, BR., and Payan, JBM. 2011. Mangosteen and rambutan. Encyclopedia of life support system (EOLSS). Diakses 17 Maret 2017 dari https://www.eolss.net/Sample-Chapters/C10/E1-05A52-00.pdf
Chitchumroonchokchai C., Riedl KM., Suksumrarn S., Clinton SK., Kinghorn AD., and Faila ML. 2012. Xanthones in mangosteen juice are absorbed and partially conjugated by healthy adults. Journal of Nutrition Vol. 142(4): 675-680
Cockerill, Franklin R., Matthew A., Wikler, Jeff Alder, et al. 2012. Performance Standards for antimicrobial susceptibility testing; twentysecond informational supplement. Clinical And Laboratory Standards Institute M100-S22 Vol. 32(3)
EUCAST. 2015. Breakpoint tables for interpretation MICs and zone diameters. Version 5.0, valid from 2015-01-01. European Committe on Antimicrobial Susceptibility Testing
Gloede, J., Scheerans, C., Derendorf, H., and Kloft, C. 2010. In vitro pharmacodynamic models to determine the effect of antibacterial drugs. J Antimicrob Chemother Vol. 65: 186-201
Ibrahim, MY., Najihah, MH., Abdalbasit, AM., Syam, M., Mahmood, AA., Siddig, IA., Ismail, AA. 2014. α-mangostin from Garcinia mangostana Linn: An updated review of its pharmacological properties. Arabian Journal of Chemistry
Ibrahim, NHS., Taher, M., Susanti, D., Amiroudine, MZM., and Ahmed, QU. 2014. Direct and indirect antimicrobial effects of α-mangostin on pathogenic microorganism. Journal of Coastal Life Medicine Vol. 2(1): 70-75
Ihsan, A., Neeraj, K., Ahmed, S., dan Javid, ID. 2014.Antibiotic resistance in uropathogenic E. coli strains isolated from non hospitalized patients in Pakistan. J. Clin Diagn Res Vol. 8(9): DC01-DC04
Jindarat, S. 2014. Xanthones from mangosteen (Garcinia mangostana): multi targeting pharmacological properties. J Med Assoc Thai Vol. 97(Suppl 2):S196-S201
Khalilullah SA., Susanti D., Saputra RW., and Nurjannah. 2011. Trends antimicrobial resistance in urinary track infections: a research at the Dr. Zainoel AbidinTeaching Hospital, Banda Aceh, Indonesia. Proceedings of the annual international conference Syiah Kuala University Vol. 1(1): 247-252
Koh JJ., Qiu S., Zou H., Lakshminarayanan R., Li J., Zhou X., et al. 2013. Rapid bacterisidal action of α- mangostin against MRSA as anoutcome of membrane targeting. Biochimia et Biophysica Acta Vol. 1828 (2): 834-844
Levison, ME., and Levison JH. 2009. Pharmacokinetic and pharmacodynamic of antibacterial agents. Infect Dis Clin North Am. Vol. 23(4): 791-820
Li, L., Brunner, I., Han AR., Hamburger, M., Kinghorn, AD., Frye, R. and Butterweck, V. 2011. Pharmacokinetics of a-mangostin in rats after intravenous and oral application. Mol. Nutr. Food Re Vol.55: S67-S74
Matuschek, E., Brown, DFJ., and Kahlmeter, G. 2013. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories. Clin Microbiol Infect Vol. 20(4): O255-266
Nguyen, PTM., and Marquis, RE. 2011. Antimicrobial actions of alpha mangostin againts oral streptococci. Canadian Journal of Mycrobiology Vol. 57(3): 217-225
Oxoid. 2010. Safety data sheet of eosin methylene blue agar (levine). Diakses 14 Maret 2015 dari www. oxoid.com/pdf/msds/en/cm0069.pdf.
Ramaiya, A., Li G., Pertiwala SM, and Johnson JJ. 2012. Single dose oral pharmacokinetic profile of α- mangostinin mice. USA: Department of Pharmacy Practice, University of Illionis at Chicago, Chicago, IL 60612
RV., Geetha, Roy, A., and T. Lakhsmi. 2011. Evaluation of anti bacterial activity of fruit rind of Garcinia mangostana Linn on enteric pathogens-an in vitro study. Asian J.Pharm Clin Res Vol. 4 (supp 2): 115-118
Sanchez, JGB., and Kouznetsov, VV. 2010. Antimycobacterial susceptibility testing methods for natural product research. Braz. J. Microbiol Vol. 41: 270-277
Satari dan Mieke Hemiawati. 2012. Multidrug Resistance (MDR) bakteri terhadap antibiotik. Bagian Oral Biologi/Mikrobiologi. Bandung: FKG Universitas Padjadjaran
Seesom W., Jaratrungtawee A., Suksamrarn S., Mekseepralard C., Ratananukul P., and Sukhumsirichart W. 2013 Antileptospiral activity of xanthones from Garcinia mangostana and synergy of gamma-mangostin with penicillin G. BMC Complementary and alternative medicine Vol.13: 182. Diakses 3 Maret 2016 dari http://www.biomedcentral.com/1472-6882/13/182
Sundaram, B., Gopalakrishnan, S., Subramanian, S., Shankaranarayanan, D., dan Kameswaran, L. Antimicrobial activities of Garcinia mangostana. 1983. Planta Med Vol.48(5): 59-60
Sukandar, Enday. 2009. Infeksi Saluran Kemih Dewasa. Dalam : Buku Ajar Ilmu Penyakit Dalam Jilid I Edisi V. Jakarta: Interna Publishing hal: 553-557
Zou, H., Koh, JJ., Li, J., Qiu, S., Aung, TT., Lin, H., Lakshminarayanan, R., Dai, X., et al. 2013. Design and syntesis of amphiphilic xanthonebased, membrane-targeting antimicrobials with improved membrane selectivity. J. Med. Chem. Vol. 56(6): 2359-2373
Downloads
Published
Issue
Section
License
Journal Author(s) Rights
To publish and disseminate research articles, Sains Medika: Jurnal Kedokteran dan Kesehatan requires non-exclusive publishing rights (transferred from author(s) to publisher). This is determined by a publishing agreement between the Author(s) and Sains Med. J. Kedokt. dan Kesehat. This agreement governs with the transfer or license of the copyright of publishing to Sains Med. J. Kedokt. dan Kesehat, while Authors still retain significant rights to use and share their own published articles. Sains Med. J. Kedokt. dan Kesehat supports the need for authors to share, disseminate and maximize the impact of their research and these rights, in any databases.
As a journal Author, you have rights for a wide variety of uses of your article, including use by your institution or company of employment. These Author rights can be exercised without the need to obtain specific permission. Authors publishing in Sains Med. J. Kedokt. dan Kesehat have wide rights to use their works for teaching and scholarly purposes without needing to seek permission, including:
- Use for classroom teaching by Author or Author's institution and presentation at a meeting or conference and distributing copies to attendees;
- Use for internal training by author's company;
- Distribution to colleagues for their research use;
- Use in a subsequent compilation of the author's works;
- Inclusion in a thesis or dissertation;
- Reuse of portions or extracts from the article in other works (with full acknowledgement of final article);
- Preparation of derivative works (other than commercial purposes) (with full acknowledgement of final article);
- Voluntary posting on open web sites operated by author or author's institution for scholarly purposes,
Authors/Readers/Third Parties can copy and redistribute the material in any medium or format, as well as remix, transform, and build upon the material for any purpose, including commercial purposes, but they must give appropriate credit (the name of the creator and attribution parties (authors detail information), a copyright notice, an open access license notice, a disclaimer notice, and a link to the material), provide a link to the license, and indicate if changes were made (Publisher indicates the modification of the material (if any) and retain an indication of previous modifications using a CrossMark Policy and information about Erratum-Corrigendum notification).
Authors/Readers/Third Parties can read, print and download, redistribute or republish the article (e.g. display in a repository), translate the article, download for text and data mining purposes, reuse portions or extracts from the article in other works, sell or re-use for commercial purposes, remix, transform, or build upon the material, they must distribute their contributions under the same license as the original Creative Commons Attribution (CC BY).
Copyright Transfer Agreement for Publishing (Publishing Right)
The Authors submitting a manuscript do so on the understanding that if accepted for publication, the non-exclusive right for publishing (publishing right) of the article shall be assigned/transferred to the Publisher of Sains Medika: Jurnal Kedokteran dan Kesehatan and Faculty of Medicine Universitas Islam Sultan Agung (FK UNISSULA).
Upon acceptance of an article, authors will be required to complete a 'Copyright Transfer Agreement for Publishing (CTAP)'. An e-mail will be sent to the Corresponding Author confirming receipt of the manuscript together with a 'Copyright Transfer Agreement for Publishing' form by online version of this agreement.
Sains Medika: Jurnal Kedokteran dan Kesehatan and Faculty of Medicine Universitas Islam Sultan Agung (FK UNISSULA), the Editors and the Advisory International Editorial Board make every effort to ensure that incorrect or misleading data, opinions or statements be published in the journal. In any way, the contents of the articles and advertisements published in the Sains Medika: Jurnal Kedokteran dan Kesehatan are sole and exclusive responsibility of their respective authors and advertisers.
Remember, even though we ask for a transfer of copyright for publishing (CTAP), our journal Author(s) retain (or are granted back) significant scholarly rights as mentioned before.
The Copyright Transfer Agreement for Publishing (CTAP) Form can be downloaded here: [Copyright Transfer Agreement for Publishing (CTAP) Form Sains Medika 2022]
The copyright form must be electronically signed and emailed to the Editorial Office in the original form below:
Dr. Suparmi, S.Si, M.Si (ERT) (Editor-in-Chief)
Editorial Office of Sains Medika: Jurnal Kedokteran dan Kesehatan
Gedung Dekanat Lantai 1 Fakultas Kedokteran Universitas Islam Sultan Agung
Jl. Raya Kaligawe KM 4 Semarang 50112, Central Java, Indonesia
Telp/Whatsapp: +62 812-2993-3369
E-mail: sainsmedika@unissula.ac.id
(This policy statements has been updated 19 October 2022)
What is Crossmark?
CrossMark, a multi-publisher initiative from CrossRef, provides a standard way for readers to locate the authoritative version of a document. Sains Medika: Jurnal Kedokteran dan Kesehatan acknowledges the significance of the integrity and completeness of the scholarly record to scholars and librarians, and places the utmost importance on preserving the credibility of its electronic archive. Clicking on the CrossMark icon will inform the reader of a document's current status and may provide additional publication record information.
